IgA Nephropathy: New Treatments Beyond Steroids

IgA nephropathy treatment has changed dramatically since 2021—steroids are no longer your only option.

In this episode, I break down the complete treatment roadmap based on the 2021 KDIGO guidelines and the latest clinical trials. This is the same tiered approach I use with my IgA nephropathy patients every day.

━━━━━━━━━━━━━━━━━━━━

WE DISCUSS:

- Tier 1 foundation therapy: RAS inhibitors, SGLT2 inhibitors, blood pressure control

- Tier 2 targeted therapies: Nefecon and Sparsentan explained

- When systemic steroids are still used (and why they're a last resort)

- Pipeline treatments: complement inhibitors and B-cell therapies

- How to talk to your nephrologist about newer treatments

━━━━━━━━━━━━━━━━━━━━

SUPPORT THE SHOW:

youtube.com/@SeanHashmiMD/join

━━━━━━━━━━━━━━━━━━━━

CONNECT:

Instagram: @seanhashmimd

Newsletter: selfprinciple.org/newsletter

YouTube: @SeanHashmiMD

━━━━━━━━━━━━━━━━━━━━

New episodes weekly on kidney health, metabolic health, longevity, and disease prevention.

Educational content only. Not medical advice. Consult your healthcare provider.

#IgANephropathy #KidneyHealth #SELFPrinciple #HealthPodcast